# Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome

> **NCT02023268** · PHASE3 · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 105 (actual)

## Conditions studied

- Dry Eye Syndrome

## Interventions

- **DEVICE:** T2762
- **DEVICE:** Vismed®

## Key facts

- **NCT ID:** NCT02023268
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2017-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023268, "Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02023268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*